65 Therapeutics, Inc.

CIK 2047647 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for 65 Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jul 6, 2026D/A0002047647-26-000002
Dec 6, 2024D0002047647-24-000001